Combining Meds Is Best

MARCH 01, 2006

A combination of therapies for the relief of rheumatoid arthritis (RA) was found to have a greater effect than either therapy alone, as reported in the January 2006 issue of Arthritis & Rheumatism. A 2-year study involved 539 patients who had had active RA for <3 years.

The patients (mean age 52) were divided into 3 groups: one group received methotrexate; another group received injections of adalimumab; and the third group received both treatments. All groups were evaluated at 6, 12, and 24 months.

After 1 year, 62% of those on combination therapy had a 50% improvement in symptoms, compared with 41% of the adalimumab group and 46% of the methotrexate group. At 2 years, nearly half of the patients on combination therapy exhibited major clinical remission—about twice as many as either of the other groups.




SHARE THIS SHARE THIS
0

Conference Coverage

Check back here regularly for live conference coverage from the American Academy of Pain Medicine and the upcoming American Pharmacists Association Meeting and Expo. 


Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.